LTBR and cancer: Independently thereof, our data shows that, in cancer cells, activation of LTβR induces secretion of pro-inflammatory cytokines known to be tumorigenic, and that this requires activation of the canonical NF-κB pathway which is, in turn, activated in a LUBAC- and linear-ubiquitin-dependent manner.